Upregulation of FOXO3 in New-Onset Type 1 Diabetes Mellitus

Table 1

Clinical characteristics of type 1 diabetes patients.

Clinical features	T1D	Severe T1D onset	Mild T1D onset
	(%)	(%)	(%)
Gender, F/M	4/24
Age^† (y)
BMI^† (kg/m^2)
HbA1c^† (%)
C peptide^† (nmol/l)
25-OH-D^† (ng/ml)
DKA^‡	12 (43)	12 (100)	16 (0)
IAA^‡	7 (25)	3 (25)	4 (25)
GADA^‡	21 (75)	9 (75)	12 (75)
IA2A^‡	23 (82)	11 (92)	12 (75)

BMI: body mass index; HbA1c: glycated haemoglobin A1c; 25-OH-D: 25-hydroxyvitamin D; DKA: diabetic ketoacidosis; IAA: antibodies to insulin; GADA: antibodies to glutamic acid decarboxylase; IA2A: antibodies to islet antigen-2; clinical features presented as ^†; ^‡number of subjects (%); , values estimated by unpaired -test, severe T1D onset vs. mild T1D onset subgroup.